c-Rel is a myeloid checkpoint for cancer immunotherapy

Li, T; Li, XY; Zamani, A; Wang, W; Lee, CN; Li, MY; Luo, G; Eiler, E; Sun, HH; Ghosh, S; Jin, J; Murali, R; Ruan, QG; Shi, WY; Chen, YH

NATURE CANCER, 2020; 1 (5):

Abstract

Immunotherapy that targets lymphoid cell checkpoints holds great promise for curing cancer. However, many cancer patients do not respond to this form ......

Full Text Link